You are here
MosquitoMate, Inc
UEI: F873ZJEX7615
# of Employees: 12
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Integration of Wolbachia-based Incompatible Insect Technique (IIT) and Auto-Dissemination Augmented by Males (ADAM) for mosquito vector control
Amount: $193,500.00Abstract In the absence of effective, approved vaccines or therapeutic measures against dengue, Zika and other mosquito borne pathogens, public health efforts must focus on the control of mosquito vec ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
Phase II: Feasibility assessment of a novel tool for mosquito vector control: Auto-Dissemination Augmented by Males (ADAM)
Amount: $1,269,152.00Project summary abstractMosquito control remains the primary tool for combating many mosquito vectored diseasessuch as DengueChikungunyaZikaand West Nilebecause no approved vaccinetherapeutant or prop ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Feasibility assessment of a novel tool for mosquito vector control: Auto-Dissemination Augmented by Males (ADAM)
Amount: $699,984.00DESCRIPTION provided by applicant Vector control remains the only means to combat many important mosquito borne pathogens including the viruses responsible for West Nile Dengue and Chikungunya A key d ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Biological vector control reducing arboviruses, including Dengue and Chikungunya
Amount: $1,799,495.00DESCRIPTION provided by applicant In the absence of effective approved drugs or vaccines vector control remains the only means of intervention for many against mosquito borne diseases This probl ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Biological vector control reducing arboviruses, including Dengue and Chikungunya
Amount: $179,379.00DESCRIPTION (provided by applicant): In the absence of effective, approved vaccines or therapeutic measures against dengue and other mosquito borne pathogens, public health efforts must focus on the c ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health